Colorectal cancer includes cancerous growths in the colon, rectum and appendix. It is the third most common form of cancer. Many colorectal cancers are thought to arise from polyps in the colon. Diagnosis is by colonoscopy. Therapy is usually through surgery, with many cases also requiring chemotherapy.
Does neural cell adhesion molecule-180 predict survival in colorectal cancer?
Colorectal Cancer :: Does neural cell adhesion molecule-180 predict survival in colorectal cancer?
When a person learns they are suffering from cancer, the first question in their mind is always: "How much time do I have?" Unfortunately, this is a question to which the researchers have long been seeking an absolute answer. Tumor progression to local invasion and metastasis are the most relevant processes for prognosis, and predictive factors for survival are sometimes the only hope for cancer patients. Tumor suppressors and adhesion molecules represent one of the primary challenges in cancer therapy.A research article published on November 7 in the World Journal of Gastroenterology addresses this question. The research team, led by Dr. Tascilar from Zonguldak Karaelmas University, investigated the frequency of NCAM-180 expression and the effect of its existence on clinical course in 26 patients suffering from colorectal cancer over a period of 4 years.
One conclusion reported by the investigators is that NCAM-180 expression was determined in only one patient with stage II cancer, with an uneventful clinical course during a follow-up period of 30 months. However, the overall rate was only 3.84%, and statistical correlation analysis of survival with NCAM-180 expression was not possible due to this low frequency.
Another interesting conclusion is that a comparison according to tumor differentiation and stage revealed that loss of NCAM-180 expression, in either well-differentiated or stage II cancer, did not result in a worse clinical course in other patients.
The authors conceded that as a consequence of the limited number of cases in their series, it might not be possible to make a generalization. Nevertheless, routine use of NCAM-180 expression as a prognostic marker for colorectal carcinoma does not seem feasible or cost-effective in clinical practice, due to it being present at a very low frequency.
The most critical deficit in the ability to treat cancer effectively is the lack of knowledge about cellular basis and markers for early diagnosis. The verification of an association between various types of malignancies and adhesion molecules might provide new targets in cancer therapy by indicating the accurate goals. Further studies with a greater number of cases are thus called for, to study the underlying mechanisms of tumor metastasis and prognosis in colorectal carcinoma.
Reference: Tascilar O, Cakmak GK, Tekin IO, Emre AU, Ucan BH, Irkorucu O, Karakaya K, Gul M, Engin HB, Comert M. Neural cell adhesion molecule-180 expression as a prognostic criterion in colorectal carcinoma: Feasible or not" World J Gastroenterol 2007; 13(41): 5476-5480
-- Article compiled by Dr. Poonam from medical news release.
(Colorectal Cancer :: Does neural cell adhesion molecule-180 predict survival in colorectal cancer? published at SpiritIndia on Saturday, November 3, 2007)
Colorectal Cancer
Search more information on Colorectal Cancer, Colorectal Cancer booksRecently posted related articles on Colorectal Cancer :
- Colorectal Cancer :: Curry-derived molecules might be too spicy for colorectal cancers
- Colorectal Cancer :: Does neural cell adhesion molecule-180 predict survival in colorectal cancer?
- Colorectal Cancer :: ImClone & Bristol-Myers Squibb with Merck KGaA to develop Erbitux in Japan
- Colorectal Cancer :: Racial and ethnic differences in colorectal cancer emphasize importance of screening
- Colorectal Cancer :: Colorectal cancer screening remains essential for elderly Americans
- Colorectal Cancer :: Interleukin-8, key marker for colorectal cancer treatment
- Colorectal Cancer :: AGA Institute statement on CT colonography study
- Colorectal Cancer :: Virtual colonoscopy - a new technology for colorectal cancer screening
- Colorectal Cancer :: New insights into colorectal cancer screening
- Colorectal Cancer :: Possible replacement found for common colorectal cancer test
Most related articles:
- Colorectal Cancer :: Does neural cell adhesion molecule-180 predict survival in colorectal cancer?- Colorectal Cancer :: Thymidylate synthase - TS marker for colorectal cancer surv - 19.3
- Colorectal Cancer :: Vaccine to treat colorectal cancer - 16.4
- Obesity :: Obesity associated with colorectal cancer - 16.1
- Colorectal Cancer :: Mutation to mismatch repair gene linked to colorectal cancer - 16
- Colorectal Cancer :: Statin use not associated with colorectal cancer risk - 15.4
- Colorectal Cancer :: Selenium May Reduce Colorectal Cancer Risk - 15.4
- Colorectal Cancer :: Survival of very elderly patients with colorectal cancer - 15.3
- Cancer :: Cancer survival rates improving with better treatment, early diagnosis - 14.6
- Colorectal Cancer :: Vitamin D reduces risk of colorectal cancer - 14.6
Colorectal Cancer - recent related articles/news stories:
- How diarrheal bacteria cause some colon cancers revealed- Cetuximab for colorectal cancer with KRAS gene
- CT colonography better for colorectal cancer screening
- Evaluating risk factors of sporadic colorectal cancer
- Colorectal cancer rising in young adults 20-29 years in US
»» Pancreatitis :: Large dose dexamethasone plays important roles in severe acute pancreatitis
«« Hepatitis C :: 24-week course of interferon-alpha therapy prolongs survival in patients hepatitis C virus
The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com